Mazzarotto R - Search Results

1

Impact of 11C-choline PET/CT on clinical decision making in recurrent prostate cancer: results from a retrospective two-centre trial.

Ceci F, Herrmann K, Castellucci P, Graziani T, Bluemel C, Schiavina R, Vollmer C, Droll S, Brunocilla E, Mazzarotto R, Buck AK, Fanti S. Ceci F, et al. Among authors: mazzarotto r. Eur J Nucl Med Mol Imaging. 2014 Dec;41(12):2222-31. doi: 10.1007/s00259-014-2872-x. Epub 2014 Aug 15. Eur J Nucl Med Mol Imaging. 2014. PMID: 25182750

2

The role of technetium-99m methoxyisobutylisonitrile scintigraphy in the planning of therapy and follow-up of patients with differentiated thyroid carcinoma after surgery.

Rubello D, Mazzarotto R, Casara D. Rubello D, et al. Among authors: mazzarotto r. Eur J Nucl Med. 2000 Apr;27(4):431-40. doi: 10.1007/s002590050527. Eur J Nucl Med. 2000. PMID: 10805117

3

Usefulness of 124I PET/CT imaging to predict absorbed doses in patients affected by metastatic thyroid cancer and treated with 131I.

Pettinato C, Monari F, Nanni C, Allegri V, Marcatili S, Civollani S, Cima S, Spezi E, Mazzarotto R, Fanti S. Pettinato C, et al. Among authors: mazzarotto r. Q J Nucl Med Mol Imaging. 2012 Dec;56(6):509-14. Q J Nucl Med Mol Imaging. 2012. PMID: 23358403 Free article. Clinical Trial.

4

11C-choline PET/CT detects the site of relapse in the majority of prostate cancer patients showing biochemical recurrence after EBRT.

Ceci F, Castellucci P, Graziani T, Schiavina R, Brunocilla E, Mazzarotto R, Ntreta M, Lodi F, Martorana G, Fanti S. Ceci F, et al. Among authors: mazzarotto r. Eur J Nucl Med Mol Imaging. 2014 May;41(5):878-86. doi: 10.1007/s00259-013-2655-9. Epub 2013 Dec 18. Eur J Nucl Med Mol Imaging. 2014. PMID: 24346416

5

Early biochemical relapse after radical prostatectomy: which prostate cancer patients may benefit from a restaging 11C-Choline PET/CT scan before salvage radiation therapy?

Castellucci P, Ceci F, Graziani T, Schiavina R, Brunocilla E, Mazzarotto R, Pettinato C, Celli M, Lodi F, Fanti S. Castellucci P, et al. Among authors: mazzarotto r. J Nucl Med. 2014 Sep;55(9):1424-9. doi: 10.2967/jnumed.114.138313. Epub 2014 Jun 16. J Nucl Med. 2014. PMID: 24935990 Free article.

6

Pretherapeutic dosimetry in patients affected by metastatic thyroid cancer using 124I PET/CT sequential scans for 131I treatment planning.

Pettinato C, Spezi E, Nanni C, Grassetto G, Monari F, Allegri V, Civollani S, Cima S, Zagni P, Mazzarotto R, Colletti PM, Rubello D, Fanti S. Pettinato C, et al. Among authors: mazzarotto r. Clin Nucl Med. 2014 Aug;39(8):e367-74. doi: 10.1097/RLU.0000000000000490. Clin Nucl Med. 2014. PMID: 24978332

7

Unusual Thyroid Carcinoma Metastases: a Case Series and Literature Review.

Farina E, Monari F, Tallini G, Repaci A, Mazzarotto R, Giunchi F, Panzacchi R, Cammelli S, Padula GD, Deodato F, Pasquali R, Fanti S, Fiorentino M, Morganti AG. Farina E, et al. Among authors: mazzarotto r. Endocr Pathol. 2016 Mar;27(1):55-64. doi: 10.1007/s12022-015-9410-7. Endocr Pathol. 2016. PMID: 26662609 Review.

8

¹⁸F-FDG Pet-Guided External Beam Radiotherapy in Iodine-Refractory Differentiated Thyroid Cancer: A Pilot Study.

Farina E, Monari F, Castellucci P, Romani F, Repaci A, Farina A, Zanirato Rambaldi G, Frezza G, Mazzarotto R, Cammelli S, Tagliaferri L, Autorino R, Deodato F, Macchia G, Cilla S, Valentini V, Fanti S, Morganti AG. Farina E, et al. Among authors: mazzarotto r. J Thyroid Res. 2017;2017:9807543. doi: 10.1155/2017/9807543. Epub 2017 Oct 19. J Thyroid Res. 2017. PMID: 29201490 Free PMC article.

9

Clinical approach in patients with metastatic differentiated thyroid carcinoma and negative 131I whole body scintigraphy: importance of 99mTc MIBI scan combined with high resolution neck ultrasonography.

Casara D, Rubello D, Saladini G, Mazzarotto R, Sotti G, Tomasella G, Pelizzo MR. Casara D, et al. Among authors: mazzarotto r. Tumori. 1999 Mar-Apr;85(2):122-7. Tumori. 1999. PMID: 10363078

10

Predictive role of changes in the tumor burden and International Metastatic Renal Cell Carcinoma Database Consortium class during active surveillance for metastatic renal cell carcinoma.

Bimbatti D, Ciccarese C, Fantinel E, Sava T, Massari F, Bisogno I, Romano M, Porcaro A, Brunelli M, Martignoni G, Mazzarotto R, Artibani W, Tortora G, Iacovelli R. Bimbatti D, et al. Among authors: mazzarotto r. Urol Oncol. 2018 Dec;36(12):526.e13-526.e18. doi: 10.1016/j.urolonc.2018.08.018. Epub 2018 Oct 6. Urol Oncol. 2018. PMID: 30301699

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

67 results

Search Page